IRIS
PASTA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.690
AS - Asia 41
SA - Sud America 9
Totale 2.740
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.690
CN - Cina 30
BR - Brasile 6
SG - Singapore 5
VN - Vietnam 4
HK - Hong Kong 2
AR - Argentina 1
CL - Cile 1
VE - Venezuela 1
Totale 2.740
Salva come PNG Salva come JPEG
Città #
Genoa 1.933
Vado Ligure 411
Genova 224
Rapallo 114
Beijing 11
Bordighera 6
Singapore 5
Ho Chi Minh City 2
Hong Kong 2
Betim 1
Brumado 1
Campo Largo 1
City Bell 1
Concepción 1
Foz do Iguaçu 1
Itaquaquecetuba 1
Rio de Janeiro 1
Vinh 1
Totale 2.717
Salva come PNG Salva come JPEG
Nome #
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 105
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 97
PCSK9 inhibitors for treating hypercholesterolemia 97
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 94
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 91
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 81
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 80
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 76
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 71
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 69
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 65
Esophageal motor disorders across ages: A retrospective multicentric analysis 64
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection 58
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 58
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study 57
Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria 56
The crohn's disease exclusion diet in adults with mild-to-moderate crohn’s disease activity: A real-world open-label randomized controlled trial 56
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 52
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 51
Clopidogrel-Induced Eosinophilic Colitis 49
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 49
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 48
Food Intolerances, Food Allergies and IBS: Lights and Shadows 48
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 48
Role of dietary intervention in patients with metabolic syndrome and {NAFLD}-{NASH} 45
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 44
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 43
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance? 42
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 42
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 42
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 42
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 41
Evaluation of adherence to Mediterranean diet, assessed by a food frequency questionnaire, in dyslipidemic patients and evaluation of dietary intervention efficacy 41
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 41
Assessing the short-term prognosis of patients with cirrhosis using the DIC scores 41
Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease 40
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 40
The levels of lipoprotein (a) in the modulation of carotid atherosclerosis risk in a group of patients with metabolic syndrome in primary prevention 39
Surveillance for hepatocellular carcinoma in patients with Primary Biliary Cholangitis: for all or just for some? 39
Exploring new noninvasive parameters to predict oesophageal varices in patients with NAFLD-associated compensated liver cirrhosis 39
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 39
Diagnostic delay in achalasia 39
Hepatocellular carcinoma in patients with Autoimmune Hepatitis 38
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis 38
Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations 37
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 36
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission 36
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 34
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis 31
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 30
null 30
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome 29
Is global score better than a single histological parameter for assessing microscopic esophagitis? 28
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 27
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration 25
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NON-CARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 23
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 21
Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis 19
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 17
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 13
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting 13
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 12
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis 11
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 11
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 9
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 8
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes 7
Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply 5
It takes two to tango: Preserving liver function competes with response to systemic therapy in patients with HCC and decompensated cirrhosis 3
Totale 2.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.164
article - articoli 13.164
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 10 41 4 4 18 5 9 3 2
2021/2022125 7 0 0 4 15 12 0 29 21 13 5 19
2022/2023150 17 19 3 5 22 19 13 11 19 1 17 4
2023/2024275 9 21 2 32 15 31 23 14 22 21 28 57
2024/20251.253 59 53 50 91 136 111 111 231 52 41 170 148
2025/20261.031 296 98 349 288 0 0 0 0 0 0 0 0
Totale 2.950